Tag: immunohistochemistry

Flagship Biosciences ActionAssays Deliver Actionable Data to Drive Immuno-Oncology Decisions

| January 16, 2018 | 0 Comments

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable data to define and advance biomarker programs. Flagship Biosciences has introduced a new menu of services to help drug developers more confidently […]

Continue Reading

Digital Pathology Advancing Medicine to the Digital Age – Part of the 25th Annual Molecular Medicine Tri-Conference

| December 6, 2017 | 0 Comments

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI’s Digital Pathology Conference in San Francisco Multiplexes IHC and Image Analysis in Immuno-Oncology Drug Development and Companion Diagnostics Michael C. Montalto, Ph.D., Executive Director, Translational Medicine, Bristol-Myers Squibb Conventional immunohistochemistry, […]

Continue Reading

HalioDx receives CLIA Compliance for Immunoscore® Colon

| June 21, 2017 | 0 Comments

HalioDx receives CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a turnaround time of 10 days Marseille, June 21, 2017 – HalioDx announced today that the company is compliant under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for its Marseille-based full service […]

Continue Reading

OptraSCAN – USCAP 2017 Immunohistochemistry/Immunofluorescence Case Contest

| February 23, 2017 | 0 Comments

OptraSCAN is inviting you to submit your best immunohistochemistry or immunofluorescence case for a chance to win the newly released “From Magic to Molecules: An Illustrated History of Disease”, as well as a PPT of the best cases submitted for your personal or teaching use. Please visit http://optrascan.com/USCAP-2017-Contest/ to submit case history, diagnosis and image […]

Continue Reading

CAP: Medicare IHC Payment Policy is Inappropriate for Services Provided to Patients

| February 12, 2014 | 0 Comments

The College of American Pathologists (CAP) has sent a letter to Ms. Clara Marie Smith (CMS) on behalf of Mickey Doyle (MD) in response to the reimbursement cuts now in effect for immunohistochemistry (IHC), essentially claiming that they don’t know anything about IHC services in its version of Kindergarten Coloring – Rules 88342 and 88343 painting […]

Continue Reading

University of Minnesota licenses multiplexing software to Flagship Biosciences

| April 14, 2011 | 0 Comments

Flagship receives exclusive license to software that pairs quantitative techniques with pathology expertise MINNEAPOLIS / ST. PAUL (04/14/2011) —The University of Minnesota has finalized a license agreement with Flagship Biosciences for software that provides quantitative analyses of protein expression levels in human tissue samples. The software, IHC Map, improves a pathologist’s ability to characterize diseased […]

Continue Reading